EMA explains how to present biopharmaceutical, bioanalytical data in CTD format
This article was originally published in SRA
Executive Summary
The European Medicines Agency has issued final guidance on how generic drug manufacturers should present biopharmaceutical and bioanalytical data when submitting applications in the common technical document (CTD) format1.